BARBARA CHAMNESS: Open Payments
NPI 1366951972 · COLORADO SPRINGS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,573 in 160 payments from 26 companies in 2025. Trend: 2023 $2,495 · 2024 $3,246 · 2025 $4,573
Food & beverage: $3,673Consulting: $900
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 23 | $1,309 |
| AstraZeneca Pharmaceuticals LP | 18 | $371 |
| GENZYME CORPORATION | 19 | $356 |
| Inspire Medical Systems, Inc. | 1 | $270 |
| United Therapeutics Corporation | 5 | $252 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $223 |
| Regeneron Healthcare Solutions, Inc. | 8 | $187 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $160 |
| Grifols USA, LLC | 10 | $137 |
| Boston Scientific Corporation | 5 | $137 |
Products named: NUCALA, DUPIXENT, INSPIRE, Tyvaso, BREZTRI, Prolastin-C Liquid, WATCHMAN FLX, Vest Therapy Und.
Industry payments across CO — which companies pay providers there.
